Brief: Singular Genomics Systems Q3 EPS USD -0.31
14/11/2023 21:01
Nov 14 (Reuters) - Singular Genomics Systems Q3 net income USD -22.36 million. * Q3 operating expenses USD 24.474 million * Q3 revenue USD 462 thousand * Q3 operating income USD -24.539 million
Recent news on Singular Genomics Systems
See all newsBrief: Singular Genomics Systems Inc Deerfield Increases Purchase Price To $24.00 Per Share
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Concentra Biosciences And Tang Capital
Singular Genomics up after Tang Capital offers to buy it
Brief: Tang Capital Management, Llc Reports 14.9% Stake In Singular Genomics Systems Inc As Of Sept 16 - SEC Filing
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Deerfield